Article
Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma.
The Prostate - 1 Apr 2016
Kibel Adam S, Ahn Jiyoung, Isikbay Masis, Klim Aleksandra, Wu William S, Hayes Richard B, Isaacs William B, Daw E Warwick
Abstract excerpt
BACKGROUND: Because a significant number of patients with prostate cancer (PCa) are diagnosed with disease unlikely to cause harm, genetic markers associated with clinically aggressive PCa have potential clinical utility. Since cell cycle checkpoint dysregulation is crucial for the development and progression of cancer, we tested the hypothesis that common germ-line variants within cell cycle genes were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
